Health For Each Health For Each
  • Cantor Global Healthcare
  • bone cancer cells
  • public health experts
  • Employees Health Benefits
  • Environmental Health
  • brain
  • DNA damage biomarkers
  • Clinical Trials


    Ketamine for Chronic Pain: Doubts and Uncertainties

    Ketamine for Chronic Pain: Doubts and Uncertainties

    A review casts doubt on ketamine and similar drugs for chronic pain relief, citing limited evidence of benefit and significant side effects. High-quality trials are needed to assess its role.


    Alzheimer’s: Cancer Drugs Show Promise in Reversing Brain Changes

    Alzheimer’s: Cancer Drugs Show Promise in Reversing Brain Changes

    Researchers identify cancer drugs (Letrozole, Irinotecan) that may reverse Alzheimer's brain changes by targeting gene expression. Combination therapy shows promise in mouse model, paving way for clinical trials.


    Glioblastoma Immunotherapy Trial: Hope for Newly Diagnosed Patients

    Glioblastoma Immunotherapy Trial: Hope for Newly Diagnosed Patients

    A new trial using immunotherapy drug Ipilimumab (Yervoy) offers hope for glioblastoma patients. The drug enhances the immune system to fight cancer cells. A previous patient had clear scans after treatment.


    HIV Vaccine Progress: mRNA Approach Shows Promise

    HIV Vaccine Progress: mRNA Approach Shows Promise

    New research shows mRNA HIV vaccine strategy triggers early immune responses in trials. The targeted vaccine approach represents a crucial step toward developing a protective HIV vaccine, using technology similar to COVID-19 vaccines.